This slide deck introduces the principles of epilepsy treatment, including antiseizure medication selection, and strategies for initial and long-term care. It addresses the medication selection in drug-resistant epilepsy, adverse effects of medications, and adherence, with special considerations for paediatrics, women of childbearing age, and developmental epileptic encephalopathies. Non-pharmacological interventions such as surgery, neurostimulation, and dietary therapy are covered, along with future directions in epilepsy care.

This slide deck was developed by Professor Dr. Jacqueline French, NYU Langone Health’s Comprehensive Epilepsy Center, USA; and Professor. Dr. Gretchen Birbeck, Rykenboer Professor of Neurology at the University of Rochester, New York, USA, in collaboration with Cambridge (a division of Prime, Cambridge, UK).

Index for
slide deck

Introduction

Introduction
Introduction
file_download Download slide in HQ
Updated treatment terminology
Updated treatment terminology

It is possible that currently available ASMs have disease-modifying effects.2 However, the design of conventional clinical trials (typically randomized controlled trials, followed by open-label extensions) would not have the capacity to demonstrate disease modification.2

file_download Download slide in HQ
Epilepsy outcomes
Epilepsy outcomes

Seizure freedom is defined as freedom from seizures for a minimum of three times the longest pre-intervention interval between seizures (determined from seizures occurring within the past 12 months) or 12 months, whichever is longer.2 Treatment failure is defined as recur…

file_download Download slide in HQ

Seizure classification and initial management

Seizure classification and initial management
Seizure classification and initial management
file_download Download slide in HQ
Provoked vs unprovoked seizures
Provoked vs unprovoked seizures

Provoked seizures are typically generalized convulsive seizures rather than focal seizures.1 With respect to alcohol, it is known that intoxication may lower the seizure threshold in patients with focal brain injuries.1 It is therefore suggested that patients presenting w…

file_download Download slide in HQ
Prognosis of provoked and unprovoked seizures
Prognosis of provoked and unprovoked seizures

In this population-based study, residents of Rochester, Minnesota were included if they had experienced a first acute symptomatic seizure or a first unprovoked seizure between 1955 and 1984.1 An acute symptomatic seizure was defined as a seizure occurring recently after a…

file_download Download slide in HQ
Narrow- vs broad-spectrum ASMs for newly diagnosed patients
Narrow- vs broad-spectrum ASMs for newly diagnosed patients

Lamotrigine and oxcarbazepine are known to occasionally aggravate myoclonic seizures and are therefore not recommended.1,4

References:

1.Löscher W, Klein P. The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS…

file_download Download slide in HQ
Commonly used antiseizure medications: mechanisms of action
Commonly used antiseizure medications: mechanisms of action

Many commonly used ASMs have multiple mechanisms of action, with the majority influencing the function of voltage-gated sodium channels, and many acting as allosteric modulators of GABA-A receptors.1

Cannabidiol does not bind to the orthostatic binding site of CB1 and CB2…

file_download Download slide in HQ
The importance of rapid management of status epilepticus
The importance of rapid management of status epilepticus

It is suggested that with respect to benzodiazepine treatment, any agent within this drug class may be used as long as it is administered promptly and in adequate doses.1 One study has shown that under-dosing of benzodiazepines was associated with a longer duration of sta…

file_download Download slide in HQ

Related content

Depression Comorbidity in Epilepsy: Identification and Screening Guidance play_circle Video play_circle
Depression Comorbidity in Epilepsy: Identification and Screening Guidance

In this video, Professor Dr. Nathalie Jetté reviews depression as a common yet often under-recognized comorbidity in epilepsy.

28.11.2025 Epilepsy
How can we address the stigma surrounding epilepsy? play_circle Video play_circle
How can we address the stigma surrounding epilepsy?

In this video, Professor Dr. Gretchen Birbeck examines epilepsy-associated stigma as a global public-health challenge

28.11.2025 Epilepsy
What can you tell us about the initial selection of an anti-seizure medication? play_circle Video play_circle
What can you tell us about the initial selection of an anti-seizure medication?

In this video, Professor Dr. Jacqueline French reviews practical, first-line decision-making for anti-seizure medication selection

28.11.2025 Epilepsy